ARTELO BIOSCIENCES, INC.

ARTL · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 7 employees
196
SEC Filings
$5.98
Close 2026-09-09
7
Employees

Business Summary

Artelo Biosciences is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing therapeutics targeting lipid-signaling modulation pathways, including the endocannabinoid system. Its pipeline includes ART27.13, a dual cannabinoid GPCR agonist in Phase 1b/2a for cancer-related anorexia; ART26.12, a FABP5 inhibitor in Phase 1 for chemotherapy-induced peripheral neuropathy; and ART12.11, a proprietary CBD-TMP cocrystal in preclinical development for anxiety, depression, and PTSD.

Latest Stock Quote

ARTL 2026-09-09 $5.98 O:$6.4147 H:$6.4147 L:$5.98 Vol:0.0M VWAP:$6.1732
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001640334-26-000368EDGAR76K words
2025-03-032024-12-310001640334-25-000335EDGAR70K words
2024-03-252023-12-310001640334-24-000473EDGAR69K words
2023-03-312022-12-310001640334-23-000509EDGAR59K words
2021-11-292021-08-310001640334-21-002983EDGAR55K words
2020-11-042020-08-310001640334-20-002722EDGAR—
2019-11-252019-08-310001640334-19-002443EDGAR—
2018-11-292018-08-310001640334-18-002309EDGAR—
2017-11-292017-08-310001640334-17-002551EDGAR—
2016-11-292016-08-310001640334-16-002136EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001640334-26-001323EDGAR24K words
2025-11-122025-09-300001640334-25-002022EDGAR22K words
2025-08-132025-06-300001640334-25-001429EDGAR52K words
2025-05-132025-03-310001640334-25-000825EDGAR37K words
2024-11-122024-09-300001640334-24-001677EDGAR38K words
2024-08-132024-06-300001640334-24-001221EDGAR38K words
2024-05-132024-03-310001640334-24-000757EDGAR37K words
2023-11-132023-09-300001640334-23-002073EDGAR36K words
2023-08-102023-06-300001640334-23-001504EDGAR35K words
2023-05-112023-03-310001640334-23-000804EDGAR34K words
2022-11-082022-09-300001640334-22-002363EDGAR36K words
2022-08-092022-06-300001640334-22-001681EDGAR35K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-270001640334-26-001421EDGAR1K words
2026-07-170001640334-26-001198EDGAR1K words
2026-03-300001640334-26-000574EDGAR23K words
2026-03-260001640334-26-000554EDGAR1K words
2026-03-180001640334-26-000475EDGAR7K words
2026-03-170001640334-26-000461EDGAR12K words
2026-03-060001640334-26-000395EDGAR1K words
2026-02-050001640334-26-000227EDGAR21K words
2026-02-050001640334-26-000221EDGAR1K words
2026-01-300001640334-26-000181EDGAR1K words

196 total filings indexed. 164 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

cancer-anorexia-cachexia-syndrome chemotherapy-induced-peripheral-neuropathy oncology-(prostate-cancer,-breast-cancer) dermatology-(psoriasis) anxiety-and-ptsd pain-and-inflammation g-protein-coupled-receptor-(gpcr)-targeting fatty-acid-binding-protein-(fabp)-inhibition cocrystal-pharmaceutical-composition endocannabinoid-system-(ecs)-modulation

Company Identity

CIK0001621221
TickerARTL
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV
HeadquartersSan Diego, California
Websitehttps://www.artelobio.com
Listed2015-10-13

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 877762a1abdde86584544a1ce0d871c98ec1b7cc64bfe4dc2ad9988ae9032db7
parent: ce523e666b0d7486d98022422a13b0308286c149a8fe5f178072a78e92cf8138
content hash: e45b708341ff67bb88b66bab6727a671774f11c3b684912b318712513eb71feb
signed: 2026-10-01T19:00:19.169Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ARTL using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ARTL, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ARTL (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.